Porphyria cutanea tarda medical therapy: Difference between revisions
Jump to navigation
Jump to search
Created page with "==Medical Therapy== Chloroquine and venesection can be part of a management strategy.<ref>{{cite journal | author=Sarkany RP | title=The management of porphyria cutane..." |
No edit summary |
||
| Line 1: | Line 1: | ||
==Medical Therapy== | ==Medical Therapy== | ||
[[Chloroquine]] and [[venesection]] can be part of a management strategy.<ref>{{cite journal | author=Sarkany RP | title=The management of porphyria cutanea tarda | journal=Clin Exp Dermatol | year=2001 | pages=225-32 | volume=26 | issue=3 | id=PMID 11422163}}</ref> | [[Chloroquine]] and [[venesection]] can be part of a management strategy.<ref>{{cite journal | author=Sarkany RP | title=The management of porphyria cutanea tarda | journal=Clin Exp Dermatol | year=2001 | pages=225-32 | volume=26 | issue=3 | id=PMID 11422163}}</ref> | ||
==References== | |||
{{reflist}} | |||
Revision as of 13:42, 3 June 2016
Medical Therapy
Chloroquine and venesection can be part of a management strategy.[1]
References
- ↑ Sarkany RP (2001). "The management of porphyria cutanea tarda". Clin Exp Dermatol. 26 (3): 225–32. PMID 11422163.